SU474981A3 - Способ получени 9(1-замещенный-4пиперидилиден)-тиоксантенов или их солей - Google Patents
Способ получени 9(1-замещенный-4пиперидилиден)-тиоксантенов или их солейInfo
- Publication number
- SU474981A3 SU474981A3 SU1848111A SU1848111A SU474981A3 SU 474981 A3 SU474981 A3 SU 474981A3 SU 1848111 A SU1848111 A SU 1848111A SU 1848111 A SU1848111 A SU 1848111A SU 474981 A3 SU474981 A3 SU 474981A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- thioxanthene
- piperidylidene
- compound
- chloroform
- methyl
- Prior art date
Links
- -1 (1-substituted-4piperidylidene) -thioxanthenes Chemical class 0.000 title description 12
- 238000000034 method Methods 0.000 title description 5
- 150000003839 salts Chemical class 0.000 title description 4
- 150000001875 compounds Chemical class 0.000 description 25
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 14
- FUSUHKVFWTUUBE-UHFFFAOYSA-N buten-2-one Chemical compound CC(=O)C=C FUSUHKVFWTUUBE-UHFFFAOYSA-N 0.000 description 10
- 238000000354 decomposition reaction Methods 0.000 description 10
- PQJUJGAVDBINPI-UHFFFAOYSA-N 9H-thioxanthene Chemical compound C1=CC=C2CC3=CC=CC=C3SC2=C1 PQJUJGAVDBINPI-UHFFFAOYSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000000155 melt Substances 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 5
- 125000000217 alkyl group Chemical group 0.000 description 5
- 239000002253 acid Substances 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 125000001188 haloalkyl group Chemical group 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- AUJMRGMSIJJVQH-UHFFFAOYSA-N CSC(C=C1)=CC2=C1SC1=CC=CC=C1C2=C1CCNCC1 Chemical compound CSC(C=C1)=CC2=C1SC1=CC=CC=C1C2=C1CCNCC1 AUJMRGMSIJJVQH-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 125000004414 alkyl thio group Chemical group 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000002026 chloroform extract Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000005075 thioxanthenes Chemical class 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- FPANKUUAVASGAH-UHFFFAOYSA-N 1-methyl-4-(2-methylsulfanylthioxanthen-9-ylidene)piperidine Chemical compound C12=CC(SC)=CC=C2SC2=CC=CC=C2C1=C1CCN(C)CC1 FPANKUUAVASGAH-UHFFFAOYSA-N 0.000 description 1
- NFASNUQKFYMUQO-UHFFFAOYSA-N 4-(1-chlorothioxanthen-9-ylidene)piperidine Chemical compound C1=2C(Cl)=CC=CC=2SC2=CC=CC=C2C1=C1CCNCC1 NFASNUQKFYMUQO-UHFFFAOYSA-N 0.000 description 1
- GHBIJVAZNYBZRA-UHFFFAOYSA-N 4-(9h-thioxanthen-10-ylidene)piperidine Chemical compound C1CNCCC1=S1C2=CC=CC=C2CC2=CC=CC=C21 GHBIJVAZNYBZRA-UHFFFAOYSA-N 0.000 description 1
- MYGXGCCFTPKWIH-UHFFFAOYSA-N 4-chloro-1-methylpiperidine Chemical compound CN1CCC(Cl)CC1 MYGXGCCFTPKWIH-UHFFFAOYSA-N 0.000 description 1
- SFCRDCSJCHFDTQ-UHFFFAOYSA-N 4-thioxanthen-9-ylidenepiperidine Chemical class C1CNCCC1=C1C2=CC=CC=C2SC2=CC=CC=C21 SFCRDCSJCHFDTQ-UHFFFAOYSA-N 0.000 description 1
- HTKABMPGOHRVCT-UHFFFAOYSA-N 5-bromopentan-2-one Chemical compound CC(=O)CCCBr HTKABMPGOHRVCT-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- DVGQMOQMDYELSZ-UHFFFAOYSA-N C1CNCCC1=C2C3=C(C=C(C=C3)Cl)SC4=CC=CC=C42 Chemical compound C1CNCCC1=C2C3=C(C=C(C=C3)Cl)SC4=CC=CC=C42 DVGQMOQMDYELSZ-UHFFFAOYSA-N 0.000 description 1
- LGHRVLCANKRKNS-UHFFFAOYSA-N COC1=CC2=C(C=C1)SC3=CC=CC=C3C2=C4CCNCC4 Chemical compound COC1=CC2=C(C=C1)SC3=CC=CC=C3C2=C4CCNCC4 LGHRVLCANKRKNS-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 1
- 229940054058 antipsychotic thioxanthene derivative Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- DZGCGKFAPXFTNM-UHFFFAOYSA-N ethanol;hydron;chloride Chemical compound Cl.CCO DZGCGKFAPXFTNM-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical group II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 150000002681 magnesium compounds Chemical class 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1695371A CH557379A (de) | 1971-11-22 | 1971-11-22 | Verfahren zur herstellung neuer 9-(4-piperidyliden)-thioxanthenderivate. |
| CH1695271A CH554893A (de) | 1971-11-22 | 1971-11-22 | Verfahren zur herstellung neuer 9-(4-piperidyliden)-thioxanthenderivate. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU474981A3 true SU474981A3 (ru) | 1975-06-25 |
Family
ID=25718740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU1848111A SU474981A3 (ru) | 1971-11-22 | 1972-11-20 | Способ получени 9(1-замещенный-4пиперидилиден)-тиоксантенов или их солей |
Country Status (13)
| Country | Link |
|---|---|
| JP (1) | JPS4862767A (cg-RX-API-DMAC10.html) |
| AT (1) | ATA987272A (cg-RX-API-DMAC10.html) |
| BE (1) | BE791699A (cg-RX-API-DMAC10.html) |
| DD (1) | DD101575A5 (cg-RX-API-DMAC10.html) |
| DE (1) | DE2256392A1 (cg-RX-API-DMAC10.html) |
| DK (1) | DK130213B (cg-RX-API-DMAC10.html) |
| FR (1) | FR2160940B1 (cg-RX-API-DMAC10.html) |
| GB (1) | GB1409893A (cg-RX-API-DMAC10.html) |
| HU (1) | HU164964B (cg-RX-API-DMAC10.html) |
| NL (1) | NL7215570A (cg-RX-API-DMAC10.html) |
| PL (1) | PL82440B1 (cg-RX-API-DMAC10.html) |
| SE (1) | SE377940B (cg-RX-API-DMAC10.html) |
| SU (1) | SU474981A3 (cg-RX-API-DMAC10.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2314305C2 (ru) * | 2001-10-25 | 2008-01-10 | БИОФРОНТЕРА ФАРМАСЮТИКАЛЗ ГмбХ | Производные 4-(тио- или селеноксантен-9-илиден)-пиперидина или акридина, фармацевтическая композиция на их основе и применение |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5283854A (en) * | 1976-01-01 | 1977-07-13 | Smithkline Corp | Piperidilidene derivatives of tricyclic compounds |
| US4356184A (en) * | 1980-06-04 | 1982-10-26 | G. D. Searle & Co. | Anti-allergic or antihypertensive 1-piperidinylmethyl benzenamines |
| ATE13297T1 (de) * | 1980-09-02 | 1985-06-15 | Sandoz Ag | Piperidyliden-derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. |
| US4777177A (en) * | 1984-10-19 | 1988-10-11 | Ciba-Geigy Corporation | Pesticidal thioxanthen-9-ylidenepiperidines |
| US5250681A (en) * | 1988-06-02 | 1993-10-05 | Ajinomoto Co., Inc. | Piperidine derivatives and hypotensives containing the same |
| CA2004211A1 (en) * | 1988-11-30 | 1990-05-31 | Masataka Syoji | Piperidine derivatives and hyportensives containing the same |
| AU620996B2 (en) * | 1989-07-04 | 1992-02-27 | Hokuriku Pharmaceutical Co. Ltd. | 4-{(dibenzocycloheptene) or (dibenzoxepin)}-1-substituted piperidines |
| CA2038417A1 (en) * | 1990-04-11 | 1991-10-12 | Yasuo Ito | Piperidine compounds, method for preparation thereof, and a pharmaceutical composition comprising the same |
| WO1999000376A1 (en) * | 1997-06-25 | 1999-01-07 | Novo Nordisk A/S | Novel heterocyclic compounds |
| US7060711B2 (en) | 2001-10-25 | 2006-06-13 | Biofrontera Bioscience Gmbh | Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist |
| WO2014117863A1 (en) | 2013-02-01 | 2014-08-07 | Biofrontera Bioscience Gmbh | Salt polymorph of thioxanthene - 9 - ylidene - 1 - methyl piperidine acid addition salts as antimigraine compounds |
-
0
- BE BE791699D patent/BE791699A/xx unknown
-
1972
- 1972-11-13 DK DK563472AA patent/DK130213B/da unknown
- 1972-11-13 SE SE7214683A patent/SE377940B/xx unknown
- 1972-11-17 DE DE2256392A patent/DE2256392A1/de active Pending
- 1972-11-17 NL NL7215570A patent/NL7215570A/xx unknown
- 1972-11-20 PL PL1972158940A patent/PL82440B1/pl unknown
- 1972-11-20 DD DD166956A patent/DD101575A5/xx unknown
- 1972-11-20 SU SU1848111A patent/SU474981A3/ru active
- 1972-11-20 GB GB5346172A patent/GB1409893A/en not_active Expired
- 1972-11-21 JP JP47117063A patent/JPS4862767A/ja active Pending
- 1972-11-21 HU HUSA2421A patent/HU164964B/hu unknown
- 1972-11-21 AT AT987272A patent/ATA987272A/de not_active Application Discontinuation
- 1972-11-22 FR FR7241416A patent/FR2160940B1/fr not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2314305C2 (ru) * | 2001-10-25 | 2008-01-10 | БИОФРОНТЕРА ФАРМАСЮТИКАЛЗ ГмбХ | Производные 4-(тио- или селеноксантен-9-илиден)-пиперидина или акридина, фармацевтическая композиция на их основе и применение |
Also Published As
| Publication number | Publication date |
|---|---|
| NL7215570A (cg-RX-API-DMAC10.html) | 1973-05-24 |
| DD101575A5 (cg-RX-API-DMAC10.html) | 1973-11-12 |
| PL82440B1 (en) | 1975-10-31 |
| DE2256392A1 (de) | 1973-05-30 |
| HU164964B (cg-RX-API-DMAC10.html) | 1974-05-28 |
| ATA987272A (de) | 1976-02-15 |
| SE377940B (cg-RX-API-DMAC10.html) | 1975-08-04 |
| DK130213B (da) | 1975-01-20 |
| DK130213C (cg-RX-API-DMAC10.html) | 1975-06-23 |
| FR2160940A1 (cg-RX-API-DMAC10.html) | 1973-07-06 |
| BE791699A (fr) | 1973-05-21 |
| JPS4862767A (cg-RX-API-DMAC10.html) | 1973-09-01 |
| GB1409893A (en) | 1975-10-15 |
| FR2160940B1 (cg-RX-API-DMAC10.html) | 1976-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3853915A (en) | 9-or 10-halo-4h-benzo{8 4,5{9 cyclo-hepta{8 1,2-b{9 thiophen-4-ones | |
| SU474981A3 (ru) | Способ получени 9(1-замещенный-4пиперидилиден)-тиоксантенов или их солей | |
| SU640662A3 (ru) | Способ получени производных имидазола или их солей | |
| FI91064C (fi) | Menetelmä terapeuttisesti vaikuttavien 3-(N-asyylietyyli-aminoalkyyli)-kromaanien ja -1,4-dioksaanien valmistamiseksi | |
| SU421187A3 (ru) | Способ получения 2-(фурилметил)-6,7- бензоморфанов | |
| US4213985A (en) | Novel 5,11-dihydro-6H-pyrido-[2,3-b][1,4]-benzodiazepine-6-ones | |
| SU591149A3 (ru) | Способ получени производных триазолоизохинолина | |
| US3073826A (en) | 3-pyrrolidylmethyl-4-quinazolones | |
| JP6256484B2 (ja) | ピリダジン化合物の製造方法 | |
| US5107057A (en) | Cyano-dienes, halopyridines, intermediates and a process for their preparation | |
| US4622326A (en) | 6H-isoxazolo(5,4-d)pyrazolo(3,4-b)pyridines, and their use as antihypertensive and analgesic agents | |
| CZ294957B6 (cs) | Způsob přípravy substituované imidazopyridinové sloučeniny | |
| SU797580A3 (ru) | Способ получени производных изохино-лиНА, иХ СОлЕй, РАцЕМАТОВ или ОпТичЕС-КиХ изОМЕРОВ | |
| US4020169A (en) | Process for preparing aryl trifluoromethylsulfides | |
| NO130329B (cg-RX-API-DMAC10.html) | ||
| SU880251A3 (ru) | Способ получени производных тиохромана или их солей | |
| US4713386A (en) | Tetrahydroazeto [2,1-a]isoquinolines and methods for treating depression | |
| US5169859A (en) | Thiazolidinone derivatives, pharmaceutical compositions containing them and process for preparing same | |
| JPH0530835B2 (cg-RX-API-DMAC10.html) | ||
| EP0294615A1 (en) | Cyclobutene-3,4-dione-intermediates and their use in the preparation of histamine h2-antagonists | |
| RU2027716C1 (ru) | Производные тиенилоксиалкиламина или их фармацевтически совместимые кислые аддитивные соли | |
| US4658029A (en) | 1-Hpyrazolo[3,4-b]pyridines | |
| EP0094691B1 (en) | Method for preparing 8-acylthio-1,2,3,4,5,6-hexahydro-2,6-methano-3,6(e),11(a)-trimethyl-3-benzazocines | |
| JPH0217549B2 (cg-RX-API-DMAC10.html) | ||
| PL166371B1 (pl) | Sposób otrzymywania nowych estrów etylowych kwasów 2,3 -dihydroimidazo [1,2 -a]pirymidyno-6-karboksylowych PL |